Loomis, Sayles & Company’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
Loomis, Sayles & Company's TDOC Position: Q3 2023 in Review
Loomis, Sayles & Company sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 193 shares — an estimated $5K sold.
Loomis, Sayles & Company first reported a position in TDOC in Q1 2017 and held it in 13 quarters. The position peaked at $39.1M in Q3 2018. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.
- Loomis, Sayles & Company reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
- Loomis, Sayles & Company sold 193 Teladoc Health shares in Q3 2023, an estimated $5K.
- Loomis, Sayles & Company first reported a position in Teladoc Health in Q1 2017 and held it in 13 quarters.
- Loomis, Sayles & Company's Teladoc Health position peaked at $39.1M in Q3 2018.
- 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.
Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.